Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ending February 29, 2024 and Year Ending February 28, 2025
January 08, 2024 at 04:09 pm EST
Share
Accolade, Inc. provided earnings guidance for the fourth quarter and year ending February 29, 2024 and year ending February 28, 2025. For the fourth quarter ending February 29, 2024, the company expects revenue between $121.5 million and $125.5 million.
For the year ending February 29, 2024, the company expects revenue between $411 million and $415 million.
For the year ending February 28, 2025, the company expects revenue growth of approximately 20%.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE, INC. 
